Replication of HIV-1 deleted Nef mutants in chronically immune activated human T cells

Virology

Volumn 303, Issue 1, 2002, Pages 138-145

  Shapira Nahor, Orit ^a,b   Maayan, Shlomo ^b   Peden, Keith W C ^c   Rabinowitz, Ruth ^a   Schlesinger, Michael ^a   Alian, Akram ^a   Panet, Amos ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

HIV 1 replication; Nef gene mutants; T cell activation

Indexed keywords

AMINO ACID; CD4 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR; HLA DR ANTIGEN; MUTANT PROTEIN; NEF PROTEIN; PHYTOHEMAGGLUTININ;

ARTICLE; CELL ACTIVITY; DISEASE DURATION; ETHIOPIA; GENE DELETION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS MUTANT; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036929558     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1643     Document Type: Article

References (58)

1. Alexander, L., Du, Z., Rosenzweig, M., Jung, J. W., and Desrosiers, R. C. (1997). A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J. Virol. 71, 6094-6099.
2. Alkhatib, G., Combadiere, C., and Broder, C. C. (1997). CCCKR5: A rantes, MIP-1a, MIP-1b receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958.
3. Anzala, O. A., Nagelkerke, N. J., Bwayo, J. J., et al. (1995). Rapid progression to disease in African sex workers with human immuno-deficiency virus type 1 infection. J. Infect. Dis. 171, 686-689.
4. Baur, A. S., Sawai, E. T., Dazin, P., Fantl, W. J., Chang-Mayer, C., and Peterlin, B. M. (1994). HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384.
5. Bentwich, Z., Kalinkovich, A., and Weisman, Z. (1995). Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol. Today 16, 187-191.
6. Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A., and Mackay, C. R. (1997). The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94, 1925-1930.
7. Bours, V., Franzoso, G., Brown, K., et al. (1992). Lymphocyte activation and the family of NF-kappa B transcription factor complexes. Curr. Top. Microbiol. Immunol. 182, 411-420.
8. Bukrinsky, M. I., Stanwick, T. L., Dempsy, M. P., and Stevenson, M. (1991). Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427.
9. Collette, Y., Chang, H. L., Cerdan, C., et al. (1996). Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression. J. Immunol. 156, 360-370.
10. Costello, P. S., Walters, A. E., Mee, P. J., et al. (1999). The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-B pathways. Proc. Natl. Acad. Sci. USA 96, 3035-3040.
11. De Ronde, A., Kalver, B., Keulen, W., Smit, L., and Goudsmit, J. (1992). Natural HIV-1 nef accelerates virus replication in primary human lymphocytes. Virology 188, 391-395.
12. Emmel, E. A., Verweij, C. L., Durand, D. B., Higgins, K. M., Lacy, E., and Crabtree, G. R. (1989). Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 246, 1617-1620.
13. Folks, T. M., Kelly, J., Benn, S., et al. (1986). Susceptibility of normal human lymphocytes to infection with HTLV III/LAV. J. Immunol. 136, 4049-4053.
14. Garcia, V., and Miller, A. D. (1991). Serine phosphorylation-independent down-regulation of cell-surface CD4 by nef. Nature 350, 508-510.
15. Geleziunas, R., Xu, W., Takeda, K., Ichijo, H., and Greene, W. C. (2001). HIV-1 Nef inhibits ASK1 dependent death signaling providing a potential mechanism for protecting the infected host cell. Nature 410, 834-838.
16. Greenway, A., Azad, A., and McPhee, D. (1995). Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69, 1842-1850.
17. Grilli, M., Chiu, J. J., and Lenardo, M. J. (1993). NF-kappa B and Rel: Participants in a multiform transcriptional regulatory system. Int. Rev Cytol. 143, 1-62.
18. Gulizia, R. J., Collman, R. G., Levy, J. A., Trono, D., and Mosier, D. E. (1997). Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice. J. Virol. 71, 4161-4164.
19. Herndon, T. M., Shan, X. C., Tsokos, G. C., and Wange, R. L. (2001). ZAP-70 and SLP-76 regulate protein kinase C-theta and NF-kappa B activation in response to engagement of CD3 and CD28. J. Immunol. 166, 5654-5664.
20. Iafrate, A. J., Bronson, S., and Skowronski, J. (1997). Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16, 673-684.
21. Kalinkovich, A., Borkow, G., Weisman, Z., Tsimanis, A., Stein, M., and Bentwich, Z. (2001). Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: Environmental and constitutive factors. Clin. Immunol. 100, 107-117.
22. Kaminchik, J., Margalit, R., and Yaish, S. (1994). Cellular distribution of HIV type 1 Nef protein: Identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrix. AIDS Res. Hum. Retroviruses 10, 1003-1010.
23. Lee, B., Sharron, M., Montaner, L. J., Weissman, D., and Doms, R. W. (1999). Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA 96, 5215-5220.
24. Luria, S., Chambers, I., and Berg, P. (1991). Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA 88, 5326-5330.
25. Mbaga, J. M., Pallangyo, K. J., Bakari, M., and Aris, E. A. (1990). Survival time of patients with acquired immune deficiency syndrome: Experience with 274 patients in Dar-es-Salaam. East Afr. Med. J. 67, 95-99.
26. Melanie, A., Graham, R., and Peden, K. W. C. (1995). Both virus and host components are important for the manifestation of a nef (-) phenotype in HIV-1 and HIV-2. Virology 213, 158-168.
27. Mellors, J. W., Kingsley, L. A., Rinaldo, C. R., Todd, J. A., Kokka, R. P., and Gupta, P. (1995). Quantification of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122, 573-579.
28. Messele, T., Abdulkadir, M., Fontanet, A. L., et al. (1999). Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin. Exp. Immunol. 115, 443-450.
29. Messele, T., Brouwer, M., Girma, M., et al. (2001). Plasma levels of viro-immunological markers in HIV-1 infected and noninfected ethiopians: Correlation with cell surface activation markers. Clin. Immunol. 98, 212-219.
30. Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C., and Feinberg, M. B. (1994). The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-113.
31. Morgan, D., and Whitworth J. (2001). The natural history of HIV-1 infection in Africa. Nat. Med. 7, 143-145.
32. Morgan, D., Mahe, C., Mayanja, B., Okongo, J. M., Lubega, R., and Whitworth, J. A. (2002a). HIV-1 infection in rural Africa: Is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 16, 597-603.
33. Morgan, D., Mahe, C., Mayanja, B., and Whitworth, J. A. (2002b). Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: Prospective cohort study. Br. Med. J. 324, 193-196.
34. Nabel, G., and Baltimore, D. (1987). An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711-713.
35. Niederman, T. M., Garcia, J. V., Hastings, W. R., Luria, S., and Ratner, L. (1992). Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells. J. Virol. 66, 6213-6219.
36. Ott, M., Emiliani, S., Van Lint, C., et al. (1997). Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 275, 1481-1485.
37. Pantaleo, G., Demarest, J. F., Soudeyns, H., et al. (1994). Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370, 463-467.
38. Peden, W. C., Emermen, M., and Montagnier, L. (1991). Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1-LAI, HIV-1-MAL, and HIV-1-ELI. Virology 185, 661-672.
39. Picard, L., Simmons, G., Power, C. A., Meyer, A., Weiss, R. A., and Clapham, P. R. (1997). Multiple extracellular domains of CCR5 contribute to HIV-1 entry and fusion. J. Virol. 71, 5003-5011.
40. Ramazaoui, S., Jouen-Beades, F., Gilbert, D., et al. (1995). During HIV infection CD4+CD38+ T cells are the predominant circulating CD4+ subset whose HLA-DR positively increases with disease progression and whose V beta repertoire is similar to that of CD4+CD38+ T cells. Clin. Immunol. Immunopathol. 77, 33-41.
41. Rhee, S. A., and Marsh, J. W. (1994). HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancement. J. Immunol. 152, 5128-5134.
42. Riley, J. L., Levine, B. L., Craighead, N., et al. (1998). Naive and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: Implications for transmission and pathogenesis. J. Virol. 72, 8273-8280.
43. Rizzarde, G. P., Barcellini, W., Tambussi, G., et al. (1996). Plasma levels of soluble CD30, tumour necrosis factor (TNF)-a and TNF receptors during primary HIV-1 infection: Correlation with HIV-1 RNA and the clinical outcome. AIDS 10, F45-F50.
44. Rizzarde, G. P., Marriott, J. B., Cookson, S., Lazzarin, A., and Dalgleish, A. G. (1998). Tumour necrosis factor (TNF) and TNF-related molecules in HIV-13 individuals: Relationship with in vitro Th1/Th2-type response. Clin. Exp. Immunol. 114, 61-65.
45. Roederer, M., Raju, P. A., Mitra, D. K., Herzenberg, L. A., and Herzen-berg, L. A. (1997). HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J. Clin. Invest. 99, 1555-1564.
46. Safrit, J. T., and Koup, R. A. (1995). The immunology of primary HIV infection: Which immune responses control HIV replication? Curr. Opin. Immunol. 7, 456-461.
47. Schrager, J. A., and Marsh, J. W. (1999). HIV-1 nef increases T cell activation in a stimulus-dependent manner. Proc. Natl. Acad. Sci. USA 96, 8167-8172.
48. Shapira-Nahor, O., Kalinkovich, A., Weisman, Z., et al. (1998). Increased susceptibility to HIV-1 infection of PBMC from chronically immune-activated individuals. AIDS 12, 1731-1733.
49. Shapira-Nahor, O., Marcus, H., Segall, H., et al. (1997). Human T cell recovered from human/BALB radiation chimeras are hypersensitive to human immunodeficiency virus type 1 infection. J. Virol. 71, 4495-4501.
50. Siekevitz, M., Josephs, S. F., Kukovich, M., Peffer, N., Wong-Staal, F., and Green, W. C. (1987). Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. Science 238, 1575-1578.
51. Skowronski, J., Parks, D., and Mariani, R. (1993). Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12, 703-713.
52. Spina, C. A., Kwoh, T. J., Chowers, M. Y., Guatelli, J. C., and Richman, D. D. (1994). The importance of nef in the induction of human immunodeficiency type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179, 915-923.
53. Spina, C. A., Prince, H. E., and Richman, D. D. (1997). Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J. Clin. Invest. 99, 1774-1785.
54. Stevenson, M., Stanwick, T. L., Dempsey, M. P., and Lamonica, C. A. (1990). HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9, 1551-1560.
55. Tong-Starksen, S. E., Luciw, P. A., and Peterlin B. M. (1987). Human immunodeficiency virus long terminal repeat responds to T-cell activation signals. Proc. Natl. Acad. Sci. USA 84, 6845-6849.
56. Wang, J. K., Kiyokawa, E., Vedin, E., and Trono, D. (2000). The nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc. Natl. Acad. Sci. USA 97, 394-399.
57. Zaunders, J. J., Geczy, A. F., Dyer, W. B., et al. (1999). Effect of long term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: Increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes. AIDS Res. Hum. Retroviruses 15, 1519-1527.
58. Zheng, L., Huang, Y., He, T., Cao, Y., and Ho, D. D. (1996). HIV-1 subtype and second receptor use. Nature 383, 768-770.